Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company is headquartered in Raleigh, North Carolina.
| Revenue (TTM) | $1.03B |
| Gross Profit (TTM) | $155.24M |
| EBITDA | $85.77M |
| Operating Margin | 3.51% |
| Return on Equity | -12.60% |
| Return on Assets | 1.88% |
| Revenue/Share (TTM) | $13.28 |
| Book Value | $6.24 |
| Price-to-Book | 1.77 |
| Price-to-Sales (TTM) | 1.02 |
| EV/Revenue | 1.918 |
| EV/EBITDA | 14.47 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 3.10% |
| Shares Outstanding | $96.08M |
| Float | $22.12M |
| % Insiders | 80.79% |
| % Institutions | 34.46% |
Volatility is currently contracting
RALEIGH, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its second quarter 2026 financial and operational results after market close on Wednesday, August 12, 2026.
Terumo, QuidelOrtho, Lumexa Imaging and BrainsWay are tackling industry headwinds through innovation, pricing and execution as healthcare demand stays resilient.
The mean of analysts' price targets for Lumexa (LMRI) points to a 44.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
The consensus price target hints at a 73.3% upside potential for Lumexa (LMRI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
RALEIGH, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, today announced the formation of a strategic joint venture with Hospital for Special Surgery (HSS), world leader in musculoskeletal health.
Lumexa Imaging Holdings, Inc. (LMRI) Q1 2026 Earnings Call Transcript
RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced results for the first quarter ended March 31, 2026, and reiterated full year 2026 guidance.
RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, today announced the addition of four new locations in 2026 as part of its continued execution against a disciplined, multi-channel growth strategy.
RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its first quarter 2026 financial and operational results after market close on Tuesday, May 12, 2026.
Proven healthcare growth leader to drive disciplined, profitable expansion and scale across Lumexa Imaging's platform Proven healthcare growth leader to drive disciplined, profitable expansion and scale across Lumexa Imaging's platform
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on LMRI and any ticker you trade — then tracks every position and per-strategy win rate.
